This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers at the TechMed Center of the University of Twente and Radboud University Medical Center have removed bloodclots with wireless magnetic robots. This innovation promises to transform treatment for life-threatening vascular conditions like thrombosis.
Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a bloodclot forms in the vein [2]. It is the third most common cardiovascular disease [2]. Deep venous anatomy and obstructions can present a multitude of complexities and mechanical challenges.
In 2023, Gujarat grappled with a cardiac crisis, as reported by the Emergency Management and Research Institute (EMRI) 108, with a staggering 72,573 cases. Studies suggest that COVID-19 can have direct effects on the cardiovascular system, leading to complications such as myocarditis, bloodclot formation, and increased risk of heart attacks.
The research is funded by a four-year, $7.8 million grant awarded to Georgia Tech by the United States Department of Defense Congressionally Directed Medical Research Programs (CDMRP) as part of the agency’s call for the development of less invasive treatment technologies for cardiovascular conditions associated with cardiomyopathy.
“I am grateful to my ACC colleagues for recognizing our work with this prestigious award,” said Chugh, associate director of the Smidt Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai. Chugh’s research is funded by the National Heart, Lung, and Blood Institute.
Link of Covid-19 to Cardiovascular Health There are various researches that signify that a vast number of people who got infected with Covid-19 infection may face some cardiovascular complications. Apart from bloodclotting, in some Covid-19 patients, a higher risk of heart failure and heart attacks has been witnessed by the hospitals.
Developed at the University of Arizona , TS23 works by blocking A2-antiplasmin, a protein in the blood that is a key determinant of whether bloodclots dissolve. I hope that TS23 will bring that much needed next wave of innovation. The trial will be led nationally by Khatri and Mistry.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content